HTS 2026 Revision 20: Pharmaceutical Section 232 Changes and Chapter 99 Checks

Identify the change before updating your entries

The USITC release page for HTS 2026 Revision 20 identifies a Commerce Department notice concerning pharmaceuticals and Proclamation 11020 as its modification source.

That source matters when deciding which products need review. Do not infer that a schedule revision implements the separate U.S.–China “30-for-30” consumer-product framework merely because the announcements occurred close together.

Start with the provisions affecting your products. A new revision number alone does not tell a purchasing or customs team whether an individual shipment’s duty treatment has changed.

Keep publication and entry dates separate

There are three relevant dates:

• September 23, 2026: Federal Register notice publication
• September 28, 2026: Revision 20 release date shown by USITC
• September 29, 2026, at 12:01 a.m. Eastern time: The annex amendments apply to goods entered for consumption or withdrawn from warehouse for consumption

The entry-related timing appears in Annexes I and II of the official notice.

For your review, identify the transaction event specified by the provision. An order date, vessel departure date, or website publication date is not a substitute for that event. If the relevant entry information is still uncertain, keep the duty conclusion provisional.

What to read in Chapter 99

Annex I amends U.S. note 40(a), (c), (c)(i), (c)(iii), and (i), and adds heading 9903.04.70. Changes cover listed classifications, pharmaceutical definitions, unpatented animal-health products, and the wording governing 9903.04.69. Read the amended provisions in Annex I.

For each SKU, separate three questions in your review:

• What is the product’s ordinary HTS classification?
• Which defined product category does it satisfy?
• Which Chapter 99 conditions apply to this transaction?

Keeping those questions separate helps prevent a code match from being mistaken for a complete eligibility analysis. It also gives the person reviewing the entry a clear place to record missing evidence.

What the additional 0% means

New heading 9903.04.70 covers the specified pharmaceutical articles and associated ingredients solely for clinical trials, research and development, or other non-commercial applications. Its rate retains the duty under the applicable subheading and adds 0%. See page 60364 of the notice.

Check both the conditions for that heading and the remaining duty calculation. The displayed additional 0% does not, by itself, establish that the entry’s total duty is zero.

For example, an invoice describing an ingredient as “for research” should prompt a review of the actual product and use. A sensible preparation file might include technical specifications, the receiving organization, and documentation explaining the intended project. This is a suggested evidence-gathering approach, not a claim that the notice mandates one uniform document package.

A working checklist for import teams

1. Save the version and source. Keep the schedule version, relevant provisions, official notice, and review date together. Preserve the earlier analysis when you make an update.
2. Recheck the product facts. Confirm the composition, form, intended use, and classification evidence. Clearly identify facts that still need verification.
3. Map the conditions. Explain why the proposed Chapter 99 heading fits. Record unresolved questions rather than allowing a keyword match to stand in for analysis.
4. Review the duty calculation in layers. Show the base rate, proposed Chapter 99 treatment, and other potentially applicable measures separately.
5. Confirm the applicable transaction date. Match the shipment record to the consumption-entry or warehouse-withdrawal event required by the provision.
6. Review before changing instructions. Ask your customs broker or trade adviser to check the proposed treatment before updating entry instructions or landed-cost assumptions.

Costvanta’s free HTS lookup can support the initial search for candidate codes, duty information, and relevant CBP rulings. For this revision, use that research alongside the official text and documented product facts.

This article provides general information, not a shipment-specific duty determination, customs instruction, or legal opinion.